SMAD4 Y353C promotes the progression of PDAC

被引：0
|
作者：
Zusen Wang
Yongxing Li
Shixiong Zhan
Lu Zhang
Shun Zhang
Qian Tang
Miaomiao Li
Zhen Tan
Shiguo Liu
Xiaoming Xing
机构：
[1] Affiliated Hospital of Qingdao University,Department of Hepatobiliary and Pancreatic Surgery
[2] Affiliated Hospital of Qingdao University,Department of Pathology
[3] Affiliated Hospital of Qingdao University,Prenatal Diagnosis Center
来源：
BMC Cancer | / 19卷
关键词：
Pancreatic ductal adenocarcinoma; SMAD4; Mutation; E-cadherin; Vimentin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] SMAD4 Y353C promotes the progression of PDAC
    Wang, Zusen
    Li, Yongxing
    Zhan, Shixiong
    Zhang, Lu
    Zhang, Shun
    Tang, Qian
    Li, Miaomiao
    Tan, Zhen
    Liu, Shiguo
    Xing, Xiaoming
    BMC CANCER, 2019, 19 (01)
  • [2] The role of Smad4/TGFB signaling in tumorigenesis of pancreatic ductal adenocarcinoma (PDAC).
    Yoo, Hannah
    Means, Anna
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 748 - 748
  • [3] Ablation of SMAD4 repression on Elf3 promotes the progression of lung cancer in vivo
    Liu, Jian
    Wang, Tianyuan
    Wu, San-pin
    Li, Jian-liang
    Demayo, Francesco J.
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/Smad4 axis driving the cells towards lethal EMT
    Faheem, Mir Mohd
    Rasool, Reyaz Ur
    Ahmad, Syed Mudabir
    Jamwal, Vijay Lakshmi
    Chakraborty, Souneek
    Katoch, Archana
    Gandhi, Sumit G.
    Bhagat, Madhulika
    Goswami, Anindya
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2020, 99 (04)
  • [5] Effects of the Smad4 C324Y mutation on thyroid cell proliferation
    D'Inzeo, Sonia
    Nicolussi, Arianna
    Nardi, Francesco
    Coppa, Anna
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (06) : 1890 - 1896
  • [6] Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS
    Li, Jinhua
    Sun, Yu Bo Yang
    Chen, Weiyi
    Fan, Jinjin
    Li, Songhui
    Qu, Xinli
    Chen, Qikang
    Chen, Riling
    Zhu, Dajian
    Zhang, Jinfeng
    Wu, Zhuguo
    Chi, Honggang
    Crawford, Simon
    Oorschot, Viola
    Puelles, Victor G.
    Kerr, Peter G.
    Ren, Yi
    Nilsson, Susan K.
    Christian, Mark
    Tang, Huanwen
    Chen, Wei
    Bertram, John F.
    Nikolic-Paterson, David J.
    Yu, Xueqing
    EMBO REPORTS, 2020, 21 (02)
  • [7] Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS
    Li J.
    Sun Y.B.Y.
    Chen W.
    Fan J.
    Li S.
    Qu X.
    Chen Q.
    Chen R.
    Zhu D.
    Zhang J.
    Wu Z.
    Chi H.
    Crawford S.
    Oorschot V.
    Puelles V.G.
    Kerr P.G.
    Ren Y.
    Nilsson S.K.
    Christian M.
    Tang H.
    Chen W.
    Bertram J.F.
    Nikolic-Paterson D.J.
    Yu X.
    The EMBO Reports, 2020, 21 (2):
  • [8] SMAD7 and SMAD4 expression in colorectal cancer progression and therapy response
    Rosic, Jovana
    Dragicevic, Sandra
    Miladinov, Marko
    Despotovic, Jovana
    Bogdanovic, Aleksandar
    Krivokapic, Zoran
    Nikolic, Aleksandra
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2021, 123
  • [9] HNF4G overexpression promotes PDAC progression and confers metformin sensitivity in patients with SMAD4-loss of function
    Wang, Chengcheng
    Wu, Chen
    Lin, Dongxin
    Zhao, Yupei
    CANCER RESEARCH, 2019, 79 (13)
  • [10] MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4
    Xia, Xiang
    Zhang, Kundong
    Cen, Gang
    Jiang, Tao
    Cao, Jun
    Huang, Kejian
    Huang, Chen
    Zhao, Qian
    Qiu, Zhengjun
    ONCOTARGET, 2015, 6 (25) : 21046 - 21063
12345